Table I.
Differentially expressed miRNAs in exosomes derived from MCs with or without HCV-E2 stimulation identified by microarray analysis.
| miRNA | Changes (times) Exo-NC vs. Exo-HCV-E2 | Regulation Exo-NC vs. Exo-HCV-E2 |
|---|---|---|
| hsa-miR-1226-5p | 5.8737507 | Up |
| hsa-miR-4773 | 5.431116 | Up |
| hsa-miR-490-5p | 5.3567324 | Up |
| hsa-miR-1539 | 5.19822718 | Up |
| hsa-miR-583 | 5.0304384 | Up |
| hsa-miR-148a-3p | 4.9687176 | Up |
| hsa-miR-17-3p | 4.849384 | Up |
| hsa-miR-7-5p | 2.615334 | Up |
| hsa-miR-140-5p | 2.509281 | Up |
| hsa-miR-625-5p | 2.4766479 | Up |
| hsa-miR-590-5p | 2.439023 | Up |
| hsa-miR-296-5p | 2.3905835 | Up |
| hsa-miR-181b-5p | 2.3839395 | Up |
| hsa-miR-132-3p | 2.3541996 | Up |
| hsa-miR-23a-5p | 2.0381694 | Up |
| hsa-miR-602 | −2.0340648 | Down |
| hsa-miR-181a-5p | −2.407178 | Down |
| hsa-miR-636 | −2.6478755 | Down |
| hsa-miR-574-3p | −6.3542786 | Down |
MC, mast cell; HCV-E2, hepatitis C virus E2 envelope glycoprotein.